Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Meta-analysis supports first-line use of inhaled corticosteroids for allergic rhinitis

Jan. 21, 1999

IntraBiotics initiates phase I clinical trial of protegrin IB-367 aerosol

Jan. 21, 1999

InKine investigates Syk kinase inhibitors for asthma, other inflammatory conditions

Jan. 19, 1999

Licensing opportunity announced: liposomal compound for treatment of ARDS

Jan. 19, 1999

New mediator of allergic asthma revealed in studies using interleukin-13 fusion protein

Jan. 19, 1999

Research at Jouveinal leads to potent and selective PDE4 inhibitors

Jan. 18, 1999

Teijin in-licenses novel asthma therapeutic from Byk Gulden

Jan. 18, 1999

Tianeptine, a 5-HT uptake enhancer, demonstrates excellent efficacy in asthma

Jan. 15, 1999

Seretide cleared for marketing in most E.U. countries

Jan. 15, 1999

Novel condensed pyridazines claimed by Takeda for allergic conditions

Jan. 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
Gensci-134: a long-acting growth hormone receptor agonist fusion protein
BioWorld Science
Gensci-134 (Genescience Pharmaceuticals Co. Ltd.) is a growth hormone receptor (GHR) agonist fusion protein that mimics the biological activity of growth hormone...